Protective Effects of Aspirin from Cardiac Hypertrophy and Oxidative Stress in Cardiomyopathic Hamsters
Figure 1
Time course of body weight (a) and the cardiac ventricular weight (mg)/body weight (g) ratio (b) in control (Cntrl) and cardiomyopathic (CM) hamster treated with placebo or 100 mg/kg/day acetylsalicylic acid (+ASA). ** versus control, +, ++ versus CM hamsters.